津普森 |
B108528-100mg |
100mg |
现货 |
1196109-52-0 |
N-(吡啶-3-基)-4-(3-((5-(三氟甲基)吡啶... |
99+%,B |
945.30
945.30
|
|
津普森 |
B108528-1g |
1g |
现货 |
1196109-52-0 |
N-(吡啶-3-基)-4-(3-((5-(三氟甲基)吡啶... |
99+%,B |
5,776.70
5,776.70
|
|
津普森 |
B108528-250mg |
250mg |
现货 |
1196109-52-0 |
N-(吡啶-3-基)-4-(3-((5-(三氟甲基)吡啶... |
99+%,B |
1,605.60
1,605.60
|
|
津普森 |
B108528-50mg |
50mg |
现货 |
1196109-52-0 |
N-(吡啶-3-基)-4-(3-((5-(三氟甲基)吡啶... |
99+%,B |
556.10
556.10
|
|
罗恩 |
R019178-10mg |
10mg |
5~7个工作日 |
1196109-52-0 |
PF-3845 N-3-吡啶-4-[[3-[[5-(三氟... PF-3845 |
98% |
235.00
235.00
|
|
罗恩 |
R019178-50mg |
50mg |
5~7个工作日 |
1196109-52-0 |
PF-3845 N-3-吡啶-4-[[3-[[5-(三氟... PF-3845 |
98% |
861.00
861.00
|
|
Selleck |
S266610mg |
10mg |
现货 |
1196109-52-0 |
PF-3845 |
|
972.12
972.12
|
|
Selleck |
S266650mg |
50mg |
现货 |
1196109-52-0 |
PF-3845 |
|
3,845.52
3,845.52
|
|
毕得 |
BD215774-50mg |
50mg |
现货 |
1196109-52-0 |
N-(吡啶-3-基)-4-(3-((5-(三氟甲基)吡啶... N-(Pyridin-3-yl)-4-(3-((5-(t... |
99+% |
806.00
806.00
|
|
毕得 |
BD215774-100mg |
100mg |
现货 |
1196109-52-0 |
N-(吡啶-3-基)-4-(3-((5-(三氟甲基)吡啶... N-(Pyridin-3-yl)-4-(3-((5-(t... |
99+% |
1,370.00
1,370.00
|
|
毕得 |
BD215774-250mg |
250mg |
现货 |
1196109-52-0 |
N-(吡啶-3-基)-4-(3-((5-(三氟甲基)吡啶... N-(Pyridin-3-yl)-4-(3-((5-(t... |
99+% |
2,327.00
2,327.00
|
|
毕得 |
BD215774-1g |
1g |
现货 |
1196109-52-0 |
N-(吡啶-3-基)-4-(3-((5-(三氟甲基)吡啶... N-(Pyridin-3-yl)-4-(3-((5-(t... |
99+% |
8,372.00
8,372.00
|
|
阿拉丁 |
P127292-10mg |
10mg |
现货 |
1196109-52-0 |
PF-3845,不可逆FAAH抑制剂 PF-3845 |
Moligand™, ≥98% |
195.90
195.90
|
|
阿拉丁 |
P127292-50mg |
50mg |
现货 |
1196109-52-0 |
PF-3845,不可逆FAAH抑制剂 PF-3845 |
Moligand™, ≥98% |
717.90
717.90
|
|
阿拉丁 |
P408694-1ml |
1ml |
现货 |
1196109-52-0 |
PF-3845 PF-3845 |
Moligand™, 10mM in DMSO |
474.90
474.90
|
|